Sutro Biopharma, Inc.
STRO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $736,670 | $603,902 | $541,020 | $1,518,486 |
| - Cash | $65,927 | $64,025 | $106,229 | $190,304 |
| + Debt | $17,661 | $219,677 | $21,397 | $203,963 |
| Enterprise Value | $688,404 | $759,554 | $456,188 | $1,532,145 |
| Revenue | $9,693 | $63,745 | $17,399 | $14,809 |
| % Growth | -84.8% | 266.4% | 17.5% | – |
| Gross Profit | $9,693 | $63,745 | $17,399 | $14,809 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$44,550 | $1,074 | -$45,571 | -$59,530 |
| % Margin | -459.6% | 1.7% | -261.9% | -402% |
| Net Income | -$56,857 | -$11,499 | -$75,968 | -$72,443 |
| % Margin | -586.6% | -18% | -436.6% | -489.2% |
| EPS Diluted | -6.7 | -1.4 | -9.1 | -8.8 |
| % Growth | -378.6% | 84.6% | -3.4% | – |
| Operating Cash Flow | -$38,189 | -$44,724 | -$67,883 | -$71,738 |
| Capital Expenditures | -$251 | -$86 | -$1,174 | -$1,068 |
| Free Cash Flow | -$38,440 | -$44,810 | -$69,057 | -$72,806 |